Metabolic perturbance in autism spectrum disorders: a metabolomics study.

Autism spectrum disorders (ASD) are a group of biological disorders with associated metabolic derangement. This study aimed to identify a pattern of metabolic perturbance in ASD using metabolomics in urinary specimens from 48 children with ASD and 53 age matched controls. Using a combination of liquid- and gas-chromatography-based mass spectrometry, we detected the levels of 82 metabolites (53 of which were increased) that were significantly altered between the ASD and the control groups using osmolality normalized data. Pattern analysis showed that the levels of several amino acids such as glycine, serine, threonine, alanine, histidine, glutamyl amino acids and the organic acid, taurine were significantly (p≤0.05) lower in ASD children. The levels of antioxidants such as carnosine were also reduced in ASD (p=0.054). Furthermore, several gut bacterial metabolites were significantly altered in ASD children who had gastrointestinal dysfunction. Overall, this study detected abnormal amino acid metabolism, increased oxidative stress, and altered gut microbiomes in ASD. The relationship of altered gut microbial co-metabolism and the disrupted metabolisms requires further investigation.

[1]  Maliha Aziz,et al.  Staphylococcus aureus CC398: Host Adaptation and Emergence of Methicillin Resistance in Livestock , 2012, mBio.

[2]  Tanmay Parekh,et al.  Application of Novel PCR-Based Methods for Detection, Quantitation, and Phylogenetic Characterization of Sutterella Species in Intestinal Biopsy Samples from Children with Autism and Gastrointestinal Disturbances , 2012, mBio.

[3]  S. Finegold.  State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. , 2011, Anaerobe.

[4]  S. van Hemert,et al.  The Potential Role of Probiotics in the Management of Childhood Autism Spectrum Disorders , 2011, Gastroenterology research and practice.

[5]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[6]  David Quig,et al.  Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity , 2011, Nutrition & metabolism.

[7]  Paul G. King,et al.  A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[8]  D. Rossignol,et al.  Mitochondrial Dysfunction Can Connect the Diverse Medical Symptoms Associated With Autism Spectrum Disorders , 2011, Pediatric Research.

[9]  James B. Adams,et al.  Gastrointestinal flora and gastrointestinal status in children with autism -- comparisons to typical children and correlation with autism severity , 2011, BMC gastroenterology.

[10]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[11]  M. Pimentel,et al.  Inflammation and microflora. , 2011, Gastroenterology clinics of North America.

[12]  Javaneh Tamiji,et al.  The Neurobiology of Lipid Metabolism in Autism Spectrum Disorders , 2011, Neurosignals.

[13]  D. Rossignol,et al.  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis , 2011, Molecular Psychiatry.

[14]  Carmela Bravaccio,et al.  Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First-degree Relatives , 2010, Journal of pediatric gastroenterology and nutrition.

[15]  John C. Lindon,et al.  Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. , 2010, Journal of proteome research.

[16]  D. Rossignol,et al.  Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. , 2010, Alternative medicine review : a journal of clinical therapeutic.

[17]  S. Buyske,et al.  Genetic variant of glutathione peroxidase 1 in autism , 2010, Brain and Development.

[18]  Pat Levitt,et al.  Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report , 2010, Pediatrics.

[19]  P. Howlin,et al.  Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. , 2009, Journal of intellectual disability research : JIDR.

[20]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[21]  Lining Guo,et al.  Untargeted Metabolomic Profiling as an Evaluative Tool of Fenofibrate-Induced Toxicology in Fischer 344 Male Rats , 2009, Toxicologic pathology.

[22]  S. Collins,et al.  The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. , 2009, Gastroenterology.

[23]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[24]  A. Calafat,et al.  Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. , 2008, Environmental research.

[25]  A. Calafat,et al.  Temporal Variability and Predictors of Urinary Bisphenol A Concentrations in Men and Women , 2007, Environmental health perspectives.

[26]  Pardis C Sabeti,et al.  Genome-wide detection and characterization of positive selection in human populations , 2007, Nature.

[27]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[28]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[29]  Stepan Melnyk,et al.  Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[31]  P. Whiteley,et al.  Spot urinary creatinine excretion in pervasive developmental disorders , 2006, Pediatrics international : official journal of the Japan Pediatric Society.

[32]  P. Elliott,et al.  Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. , 2006, Analytical chemistry.

[33]  S. Buyske,et al.  Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism , 2006, BMC Genetics.

[34]  T P Stein,et al.  Increased excretion of a lipid peroxidation biomarker in autism. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[35]  Anne L McCartney,et al.  Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. , 2005, Journal of medical microbiology.

[36]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[37]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[38]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[39]  S. Finegold,et al.  Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children , 2004, Applied and Environmental Microbiology.

[40]  H. Savaş,et al.  Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[41]  J. Doré,et al.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon , 2003, Gut.

[42]  M. Chez,et al.  Double-Blind, Placebo-Controlled Study of L-Carnosine Supplementation in Children With Autistic Spectrum Disorders , 2002, Journal of child neurology.

[43]  O. Yorbik,et al.  Investigation of antioxidant enzymes in children with autistic disorder. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[44]  Haroun Shah,et al.  Gastrointestinal microflora studies in late-onset autism. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  C P Buchanan,et al.  Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism , 2000, Journal of child neurology.

[46]  J. Papadimitriou,et al.  Gastrointestinal abnormalities in children with autistic disorder. , 1999, The Journal of pediatrics.

[47]  A. Fattal-Valevski,et al.  Characterization and comparison of autistic subgroups: 10 years' experience with autistic children , 1999, Developmental medicine and child neurology.

[48]  L. Borjas,et al.  Plasma excitatory amino acids in autism. , 1996, Investigacion clinica.

[49]  W. Shaw,et al.  Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. , 1995, Clinical chemistry.

[50]  E. Eck,et al.  Serum serotonin, lactate and pyruvate levels in infantile autistic children. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[51]  K. Grotemeyer,et al.  Serotonin and amino acid content in platelets of autistic children , 1993, Acta psychiatrica Scandinavica.

[52]  J. Blass,et al.  Autism and lactic acidosis , 1985, Journal of autism and developmental disorders.

[53]  J. Sverd,et al.  Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children. , 1980, Neuropediatrics.

[54]  R. Christie,et al.  Amino compounds and organic acids in CSF, plasma, and urine of autistic children. , 1978, Biological psychiatry.

[55]  K. Tada,et al.  Urocanic aciduria: a defect in the urocanase activity in the liver of a mentally retarded. , 1971, The Tohoku journal of experimental medicine.

[56]  J. Reinhardt,et al.  A review of the life history, invasion process, and potential management of Clavelina lepadiformis Müller, 1776: a recent invasion of the northwest Atlantic , 2012 .

[57]  P. Whorwell,et al.  Abdominal Bloating and Distension: What Is the Role of the Microbiota , 2011, Digestive Diseases and Sciences.

[58]  J. Holden,et al.  The G22A Polymorphism of the ADA Gene and Susceptibility to Autism Spectrum Disorders , 2008, Journal of autism and developmental disorders.

[59]  S. Buyske,et al.  Risk of autistic disorder in affected offspring of mothers with a glutathione S-transferase P1 haplotype. , 2007, Archives of pediatrics & adolescent medicine.